Home
°øÁö»çÇ×
CSL ¾Ù¹ü
¹«·á À̸ÞÀÏ @cell-signaling °èÁ¤ ¸¸µé±â

Designed
    by Heidi-Dream

 

´ë»çÁõÈıº ¹× ¼¼Æ÷ ½ÅÈ£Àü´Þ ¿¬±¸½Ç
(Matabolic Syndrome and Cell Signaling Laboratory)

 

 

¡á  Home > °øÁö»çÇ×

¹Ú·æÁø ÇлýÀÇ 2¹øÂ° LETM1 paper°¡ Cancer Research¿¡ äÅõǾú½À´Ï´Ù ÃàÇÏÇÕ´Ï´Ù
 cell  02-12
From: kyle.overturf@aacr.org [mailto:kyle.overturf@aacr.org]
Sent: Monday, February 09, 2009 2:16 PM
To: insulin@cnu.ac.kr
Subject: CANCER RESEARCH CAN-08-3235R1 -- Decision Rendered

Re: CAN-08-3235R1
Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death in HeLa cells

Dear Dr. Park:

I am pleased to inform you that your CANCER RESEARCH manuscript CAN-08-3235R1,
Association of LETM1 and MRPL36 contributes to the regulation of mitochondrial ATP production and necrotic cell death in HeLa cells, has been accepted for publication in CANCER RESEARCH.

The scheduled publication date of your article will be provided on your proofs, which you will receive page proofs within 4 to 5 weeks. If you expect your address to change within that time, please inform us immediately by contacting the Editorial Office either via e-mail to cancerres@aacr.org, or via fax to (215)440-9354. If your manuscript submission information included an e-mail address, you will receive electronic page proofs. If you do not have access to e-mail, you will receive hard copy page proofs.

Please note that the assignment to which section of the journal your article will appear is made at the discretion of the editors.

Thank you in advance for your cooperation.

Sincerely,
Carl-Henrik Heldin, Ph.D.
Senior Editor
 LIST   
  23   2010³â »õÇØ º¹ ¸¹ÀÌ ¹ÞÀ¸¼¼¿ä  cell 01-09  
  22   ·æÁøÇлýÀÇ 3¹øÂ° ³í¹®ÀÌ BMC cell Biology¿¡ äÅõǾú½À´Ï´Ù  cell 08-20  
  21   ·æÁøÇлý ³í¹®À¸·Î ±³¼ö´ÔÀÌ ½Å¹®¿¡ ³ª¿Ô¾î¿ä  cell 04-15  
    ¹Ú·æÁø ÇлýÀÇ 2¹øÂ° LETM1 paper°¡ Cancer Research¿¡ äÅõǾú½À´Ï´Ù ÃàÇÏÇÕ´Ï´Ù  cell 02-12  
  19   ±³¼ö´ÔÀÇ paperµµ JBC¿¡ äÅÃÀÌ µÇ¾ú½À´Ï´Ù  cell 01-10  
  18   ¹Ú·æÁø ÇлýÀÇ LETM1 paper°¡ cellular signaling¿¡ äÅõǾú½À´Ï´Ù  cell 01-10  
  17   ¿©·¯°¡Áö ¿¬±¸½Ç¿øµéÀÇ ÀϵéÀ» ÃàÇÏÇÕ´Ï´Ù  cell 03-26  
  16   2008³âÀÌ ¹à¾Ò½À´Ï´Ù  cell 02-05  
  15   Your manuscript has been accepted for publication as a JBC Papers  cell 12-13  
  14   Post-doctoral position at the FMI Basel  cell 03-08  
  13   2007³â 2¿ù 25ÀÏ¿¡ ¾ç±ÝÁø ÇлýÀÌ °áÈ¥ÇÕ´Ï´Ù  cell 02-11  
  12   ¼®»ç ½ÅÀÔ»ý ³ë¹Ì¶õÀ» ¼Ò°³ÇÕ´Ï´Ù..  cell 11-13  
  11   ¹Ú»ç°úÁ¤ ¾ç±ÝÁø ÇлýÀÌ ÇÐÀ§ ³í¹®À» ¾²°í ÀÖ½À´Ï´Ù  cell 10-19  
  10   ¼®»ç ½ÅÀÔ»ý ÀÌ¿Á¹®À» ȯ¿µÇÕ´Ï´Ù  cell 08-30  
  9   20th IUBMB (Kyoto, Japan)  cell 06-26  
  8   »õ½Ä±¸ ¼Ò°³ - ½Å À»¼ø (¼®»ç 1±â)  cell 03-03  
  7   »õÇØ º¹ ¸¹ÀÌ ¹ÞÀ¸¼¼¿ä  cell 12-11  
  6   11¿ù 10-11ÀÏ Çѱ¹ µ¶¼ºÇÐȸ  cell 09-29  
  5   11¿ù 03-04ÀÏ ´ëÇÑ ¾à¸®ÇÐȸ Âü°¡ Áغñ  cell 09-29  
  4   10¿ù 17-18ÀÏ Çѱ¹ºÐÀÚ¼¼Æ÷»ý¹°ÇÐȸ Âü°¡ Áغñ  cell 09-29  
[1][2] 3 [4]   SEARCH
Copyright 1999-2026 Zeroboard / skin by GGAMBO

 

 


Matabolic Syndrome and Cell Signaling Laboratory in Institute for Cancer Research
Department of Pharmacology, College of Medicine, Chungnam National University
266 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea
Tel: +82-42-280-6768 Fax: +82-42-585-6627
COPYRIGHT ¨Ï 2009 Metabolic Syndrome and Cell Signaling Laboratory, ALL RIGHTS RESERVED.